Nano-X Imaging Ltd. (NNOX) Form 6-K — Oct 16, 2026
Nanox furnished preliminary unaudited Q3 2026 results, expecting revenue of approximately $4.3 to $4.4 million, up from $3.4 million in the year-ago quarter. AI and software revenue jumped to $1.0 million from $0.1 million, mainly from consolidating Nanox Health IT, while teleradiology was flat at $3.1 million. The company also announced a distribution agreement with Technologic s.r.l. to commercialize Nanox.AI's Bone Solution in Italy, and its Nanox.ARC X was named one of TIME's Best Inventions of 2026.
Key figures
- Revenue
- $4.3-4.4 million (preliminary Q3 2026)
- Revenue Yoy
- +~27% vs $3.4 million in Q3 2025
- Cash Position
- ~$26.0 million as of September 30, 2026 (vs $60.0 million as of December 31, 2025)
- Ai software revenue
- $1.0 million vs $0.1 million prior year
- Teleradiology revenue
- $3.1 million (flat vs prior year)
- Imaging systems and oem revenue
- $0.3 million vs $0.2 million prior year
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.